Stay updated on Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page.

Latest updates to the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page’s displayed revision/version label was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check37 days agoChange DetectedSite revision updated from v3.4.2 to v3.5.0. No changes to the study details, eligibility, outcomes, or navigation are indicated.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check87 days agoChange DetectedAdded a glossary toggle, introduced a 'Last Update Submitted that Met QC Criteria' metadata item, and updated capitalization for FEAR data and the page revision to v3.4.0, all of which are UI/metadata refinements rather than changes to the core study content.SummaryDifference0.2%

Stay in the know with updates to Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page.